V

Veeva Systems
D

VEEV

223.190
USD
6.32
(2.91%)
Market Closed
Volume
35,665
EPS
6
Div Yield
-
P/E
55
Market Cap
36,234,975,286
Related Instruments
    CRM
    CRM
    2.64
    (0.81%)
    326.93 USD
    FTNT
    FTNT
    2.960
    (3.14%)
    97.200 USD
    HUBS
    HUBS
    21.13
    (3.00%)
    724.96 USD
    M
    MDB
    4.88
    (1.93%)
    257.86 USD
    NOW
    NOW
    25.09
    (2.34%)
    1,096.76 USD
    O
    OKTA
    2.100
    (2.41%)
    89.410 USD
    WDAY
    WDAY
    1.080
    (0.43%)
    250.720 USD
    ZS
    ZS
    4.300
    (2.29%)
    191.820 USD
    More
News

Title: Veeva Systems

Sector: Healthcare
Industry: Health Information Services
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.